Pyxis Oncology (PYXS)

• Market cap: $221M
• 1 day: 4.09%
• 5 days: 2.89%
• 1 month: 60.36%
• 3 months: 217.86%
• 6 months: 223.64%
• Year to date: 110.65%
• 1 year: 0%
• 5 years: -73.03%
• 10 years: -73.03%
• Sector: Healthcare
• Industry: Biotechnology

About: Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Employees: 44